葛兰素史克(US)吧
排序:
评论时间
  • 评论时间
  • 发帖时间
阅读评论标题 作者 最后更新
798 4 资讯 葛兰素史克:未来五年将在美国投资300亿美元 用于研发 葛兰素史克(US)资讯 09-17 08:34
29 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 09-16 21:26
27 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 09-15 20:55
29 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 09-12 18:07
30 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 09-11 19:33
37 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 09-10 23:50
31 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 09-10 18:07
32 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 09-09 19:34
34 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 09-08 19:23
39 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 09-05 19:17
41 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 09-04 23:37
40 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 09-04 19:04
38 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 09-03 18:54
37 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 09-02 21:56
40 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 09-02 20:35
36 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 09-02 19:10
35 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 08-29 18:54
40 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 08-28 18:16
44 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 08-27 20:09
39 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 08-26 19:38
42 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 08-22 21:32
43 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 08-21 23:15
44 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 08-21 18:28
42 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 08-20 18:15
55 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 08-19 23:17
45 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 08-19 18:17
48 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 08-18 18:22
49 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 08-15 18:34
49 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 08-14 18:14
50 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 08-13 18:10
49 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 08-13 00:46
45 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 08-12 18:11
49 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 08-11 19:06
42 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 08-11 18:47
64 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 08-08 18:40
57 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 08-08 18:33
54 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 08-07 19:56
54 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 08-06 18:43
50 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 08-05 19:18
58 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 08-04 18:34
60 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 08-02 01:04
61 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 08-01 22:52
64 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 07-31 20:17
241 0 资讯 葛兰素史克二季度总营收80亿英镑,同比增长6% 葛兰素史克(UK)资讯 07-31 19:45
4637 0 120亿美元天价合作!跨国药企疯狂买买买图什么? 财联社 07-31 19:01
61 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 07-30 23:10
65 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 07-30 18:27
65 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 07-29 18:57
3563 3 资讯 恒瑞医药与GSK达成授权交易:总金额最高120亿美元 恒瑞医药资讯 07-29 07:36
13262 9 资讯 4千亿巨头涨停!恒瑞医药回应125亿美元GSK合作细节 恒瑞医药资讯 07-29 04:04
60 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 07-28 23:35
69 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 07-28 18:46
4273 14 资讯 恒瑞医药与GSK达成授权合作,首付款5亿美元 恒瑞医药资讯 07-28 18:28
553 1 如何看待恒瑞医药获得GSK大单,股价再创新高? 小富财经 07-28 10:11
69 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 07-25 20:13
64 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 07-25 01:49
62 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 07-25 01:42
71 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 07-24 01:38
67 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 07-24 00:58
69 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 07-22 18:26
4181 0 “疗效不是一切”,来自GSK的ADC警示 氨基观察 07-22 12:22
70 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 07-21 18:33
81 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 07-18 23:31
59 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 07-18 18:59
77 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 07-18 18:54
77 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 07-17 22:42
63 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 07-17 22:12
80 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 07-16 18:45
46 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 07-15 23:05
50 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 07-15 18:18
55 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 07-15 01:27
46 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 07-14 22:19
50 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 07-14 20:46
244 0 资讯 葛兰素史克公司:FDA已接受其呼吸道合胞病毒疫苗扩大 葛兰素史克(US)资讯 07-14 14:50
43 0 公告 Report of foreign issuer [Rules 13a-16 and 15d-16] 葛兰素史克(US)资讯 07-11 18:31
发表新主题
悬赏提问
帖子不见了!怎么办?   
   请登录 登录 | 5秒注册 作者: 退出 
温馨提示: 1.根据《证券法》规定,禁止编造、传播虚假信息或者误导性信息,扰乱证券市场;2.用户在本社区发表的所有资料、言论等仅代表个人观点,与本网站立场无关,不对您构成任何投资建议。用户应基于自己的独立判断,自行决定证券投资并承担相应风险。《东方财富社区管理规定》

扫一扫下载APP

扫一扫下载APP
信息网络传播视听节目许可证:0908328号 经营证券期货业务许可证编号:913101046312860336 违法和不良信息举报:021-34289898 举报邮箱:jubao@eastmoney.com
沪ICP证:沪B2-20070217 网站备案号:沪ICP备05006054号-11 沪公网安备 31010402000120号 版权所有:东方财富网 意见与建议:021-54509966/952500